These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8628854)

  • 21. Fibroadenomas: computer-assisted quantitative evaluation of contrast-enhanced power Doppler features and correlation with histopathology.
    Huber S; Vesely M; Zuna I; Delorme S; Czembirek H
    Ultrasound Med Biol; 2001 Jan; 27(1):3-11. PubMed ID: 11295265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast lesion characterization with contrast-enhanced US. Work in progress.
    Caruso G; Ienzi R; Cirino A; Salvaggio G; Campione M; Lagalla R; Cardinale A
    Radiol Med; 2002; 104(5-6):443-50. PubMed ID: 12589266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can Doppler or contrast-enhanced ultrasound analysis add diagnostically important information about the nature of breast lesions?
    Stanzani D; Chala LF; Barros Nd; Cerri GG; Chammas MC
    Clinics (Sao Paulo); 2014 Feb; 69(2):87-92. PubMed ID: 24519198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results.
    Jung EM; Jungius KP; Rupp N; Gallegos M; Ritter G; Lenhart M; Clevert DA; Kubale R
    Clin Hemorheol Microcirc; 2005; 33(2):109-20. PubMed ID: 16151258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced color Doppler sonography of uveal melanomas.
    Lemke AJ; Hosten N; Richter M; Bechrakis NE; Foerster P; Puls R; Gutberlet M; Felix R
    J Clin Ultrasound; 2001 May; 29(4):205-11. PubMed ID: 11323774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of intravenous contrast material in transcranial sonography.
    Murphy KJ; Bude RO; Dickinson LD; Rubin JM
    Acad Radiol; 1997 Aug; 4(8):577-82. PubMed ID: 9261457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Italian experience with SH U 508 A (Levovist) in breast disease.
    Spreafico C; Lanocita R; Frigerio LF; Di Tolla G; Garbagnati F; Milella M; Marchianò A; Piragine G; Damascelli B
    Radiol Med; 1994 May; 87(5 Suppl 1):59-64. PubMed ID: 8209019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced ultrasound examination of the breast: a literature review.
    Drudi FM; Cantisani V; Gnecchi M; Malpassini F; Di Leo N; de Felice C
    Ultraschall Med; 2012 Dec; 33(7):E1-E7. PubMed ID: 22623129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D-power Doppler ultrasound of breast lesions with a microbubble contrast agent.
    Krestan CR; Riedl C; Memarsadeghi M; Rudas M; Pfarl G; Helbich TH
    Acad Radiol; 2002 Aug; 9 Suppl 2():S384-5. PubMed ID: 12188284
    [No Abstract]   [Full Text] [Related]  

  • 30. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
    Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
    J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of breast lesions using Doppler with contrast agents.
    Martínez AM; Medina CJ; Bustos C; Hernández JA
    Eur J Gynaecol Oncol; 2003; 24(6):527-30. PubMed ID: 14658595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations.
    Liu H; Jiang YX; Liu JB; Zhu QL; Sun Q
    Breast; 2008 Oct; 17(5):532-9. PubMed ID: 18534851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of power Doppler techniques and ultrasound contrast enhancement in the differential diagnosis of focal breast lesions.
    Schroeder RJ; Bostanjoglo M; Rademaker J; Maeurer J; Felix R
    Eur Radiol; 2003 Jan; 13(1):68-79. PubMed ID: 12541112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography.
    Stuhrmann M; Aronius R; Schietzel M
    AJR Am J Roentgenol; 2000 Dec; 175(6):1585-9. PubMed ID: 11090380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity.
    Forsberg F; Kuruvilla B; Pascua MB; Chaudhari MH; Merton DA; Palazzo JP; Goldberg BB
    Ultrasound Med Biol; 2008 Sep; 34(9):1365-72. PubMed ID: 18436369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dynamic assessment of contrast medium enhancement in Doppler ultrasound imaging. Current status].
    Huber S; Delorme S; Zuna I
    Radiologe; 1998 May; 38(5):390-3. PubMed ID: 9646345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-galactose-based signal-enhanced color Doppler sonography of breast tumors and tumorlike lesions.
    Schroeder RJ; Maeurer J; Vogl TJ; Hidajat N; Hadijuana J; Venz S; Weber S; Felix R
    Invest Radiol; 1999 Feb; 34(2):109-15. PubMed ID: 9951790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of real-time gray-scale contrast-enhanced ultrasound in the diagnosis of benign and malignant breast lesions].
    Zhang J; Jiang YX; Dai Q; Sun Q; Lü K; Tan L; Gao P
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):49-53. PubMed ID: 18361053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of contrast enhancement in MR imaging and power Doppler ultrasonography of solid breast lesions.
    Reinikainen H; Pääkkö E; Suramo I; Päivänsalo M; Jauhiainen J; Rissanen T
    Acta Radiol; 2002 Sep; 43(5):492-500. PubMed ID: 12423460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic carcinoma versus chronic focal pancreatitis: contrast-enhanced power Doppler ultrasonography findings.
    Scialpi M; Midiri M; Bartolotta TV; Cazzolla MP; Rotondo A; Resta MC; Lagalla R; Cardinale AE
    Abdom Imaging; 2005; 30(2):222-7. PubMed ID: 15654578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.